The Efficacy of Alendronate Versus Denosumab on Major Osteoporotic Fracture Risk in Elderly Patients With Diabetes Mellitus: A Danish Retrospective Cohort Study
ObjectivePatients with diabetes mellitus have an increased risk of fractures; however, the underlying mechanism is largely unknown. We aimed to investigate whether the risk of major osteoporotic fractures in diabetes patients differs between subjects initiated with alendronate and denosumab, respect...
Збережено в:
| Автори: | , , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
Frontiers Media S.A.
2022-01-01
|
| Серія: | Frontiers in Endocrinology |
| Предмети: | |
| Онлайн доступ: | https://www.frontiersin.org/articles/10.3389/fendo.2021.826997/full |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|